Medicus Pharma Ltd.
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Medicus Pharma Ltd. (MDCX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/14/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Termination of a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 09/14/2026 | Ownership disclosure | Form SC 13D filed with the SEC | View document ↗ |
| 09/11/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.